Gainor Highlights Future of Immunotherapy in Stage III Lung Cancer Treatment
Justin F. Gainor, MD, highlights the evolving paradigm for the use of immunotherapy in the treatment of patients with unresectable locally advanced non–small cell lung cancer.
Source: OncLive